Follow
Gregory Lizée
Gregory Lizée
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Loss of PTEN promotes resistance to T cell–mediated immunotherapy
W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ...
Cancer discovery 6 (2), 202-216, 2016
13882016
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma
DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ...
Clinical cancer research 19 (5), 1225-1231, 2013
9942013
PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines
W Peng, C Liu, C Xu, Y Lou, J Chen, Y Yang, H Yagita, WW Overwijk, ...
Cancer research 72 (20), 5209-5218, 2012
4882012
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients
LG Radvanyi, C Bernatchez, M Zhang, PS Fox, P Miller, J Chacon, R Wu, ...
Clinical Cancer Research 18 (24), 6758-6770, 2012
4542012
BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice
C Liu, W Peng, C Xu, Y Lou, M Zhang, JA Wargo, JQ Chen, HS Li, ...
Clinical cancer research 19 (2), 393-403, 2013
4032013
Plasmacytoid dendritic cells induce NK cell–dependent, tumor antigen–specific T cell cross-priming and tumor regression in mice
C Liu, Y Lou, G Lizée, H Qin, S Liu, B Rabinovich, GJ Kim, YH Wang, Y Ye, ...
The Journal of clinical investigation 118 (3), 1165-1175, 2008
3962008
Oncogenic BRAF (V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma
JS Khalili, S Liu, TG Rodríguez-Cruz, M Whittington, S Wardell, C Liu, ...
Clinical Cancer Research 18 (19), 5329-5340, 2012
3262012
Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain
G Lizée, G Basha, J Tiong, JP Julien, M Tian, KE Biron, WA Jefferies
Nature immunology 4 (11), 1065-1073, 2003
2552003
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
S Yoshihama, J Roszik, I Downs, TB Meissner, S Vijayan, B Chapuy, ...
Proceedings of the National Academy of Sciences 113 (21), 5999-6004, 2016
2422016
Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses
W Peng, Y Ye, BA Rabinovich, C Liu, Y Lou, M Zhang, M Whittington, ...
Clinical Cancer Research 16 (22), 5458-5468, 2010
2402010
Harnessing the power of the immune system to target cancer
G Lizée, WW Overwijk, L Radvanyi, J Gao, P Sharma, P Hwu
Annual review of medicine 64, 71-90, 2013
1822013
Combination Small Molecule MEK and PI3K Inhibition Enhances Uveal Melanoma Cell Death in a Mutant GNAQ- and GNA11-Dependent Manner
JS Khalili, X Yu, J Wang, BC Hayes, MA Davies, G Lizee, B Esmaeli, ...
Clinical Cancer Research 18 (16), 4345-4355, 2012
1792012
Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression
G Lizée, JL Aerts, MI Gonzales, N Chinnasamy, RA Morgan, SL Topalian
Human gene therapy 14 (6), 497-507, 2003
1632003
BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma
SD Bradley, Z Chen, B Melendez, A Talukder, JS Khalili, ...
Cancer immunology research 3 (6), 602-609, 2015
1562015
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Y Hailemichael, DH Johnson, N Abdel-Wahab, WC Foo, SE Bentebibel, ...
Cancer Cell 40 (5), 509-523. e6, 2022
1452022
Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo
Y Lou, G Wang, G Lizée, GJ Kim, SE Finkelstein, C Feng, NP Restifo, ...
Cancer research 64 (18), 6783-6790, 2004
1432004
Human dendritic cells in cancer
E Kvedaraite, F Ginhoux
Science immunology 7 (70), eabm9409, 2022
1292022
Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms
G Lizée, LG Radvanyi, WW Overwijk, P Hwu
Clinical cancer research 12 (16), 4794-4803, 2006
1292006
RNA editing derived epitopes function as cancer antigens to elicit immune responses
M Zhang, J Fritsche, J Roszik, LJ Williams, X Peng, Y Chiu, CC Tsou, ...
Nature communications 9 (1), 3919, 2018
1282018
MHC class I endosomal and lysosomal trafficking coincides with exogenous antigen loading in dendritic cells
G Basha, G Lizée, AT Reinicke, RP Seipp, KD Omilusik, WA Jefferies
PloS one 3 (9), e3247, 2008
1222008
The system can't perform the operation now. Try again later.
Articles 1–20